Deuteration
Journal
RSC advances
ISSN: 2046-2069
Titre abrégé: RSC Adv
Pays: England
ID NLM: 101581657
Informations de publication
Date de publication:
15 Oct 2020
15 Oct 2020
Historique:
received:
20
05
2020
accepted:
11
10
2020
entrez:
6
5
2022
pubmed:
20
10
2020
medline:
20
10
2020
Statut:
epublish
Résumé
The inducible isoenzyme cyclooxygenase-2 (COX-2) is closely associated with chemo-/radioresistance and poor prognosis of solid tumors. Therefore, COX-2 represents an attractive target for functional characterization of tumors by positron emission tomography (PET). In this study, the celecoxib derivative 3-([
Identifiants
pubmed: 35517533
doi: 10.1039/d0ra04494f
pii: d0ra04494f
pmc: PMC9057277
doi:
Types de publication
Journal Article
Langues
eng
Pagination
38601-38611Informations de copyright
This journal is © The Royal Society of Chemistry.
Déclaration de conflit d'intérêts
There are no conflicts to declare.
Références
Eur J Nucl Med Mol Imaging. 2006 Sep;33(9):1017-24
pubmed: 16699766
Curr Med Chem. 2013;20(35):4350-69
pubmed: 24059237
Gut. 2005 Nov;54(11):1509-14
pubmed: 16227351
Inflammation. 2004 Oct;28(5):285-90
pubmed: 16134002
PLoS One. 2017 May 2;12(5):e0176606
pubmed: 28464017
ACS Med Chem Lett. 2011 Feb 10;2(2):160-164
pubmed: 21318094
Anticancer Drugs. 2004 Mar;15(3):255-63
pubmed: 15014359
Cancer Res. 2004 Feb 15;64(4):1444-51
pubmed: 14973075
Ann Nucl Med. 2005 Oct;19(7):617-25
pubmed: 16363629
Pharmacogenet Genomics. 2012 Apr;22(4):310-8
pubmed: 22336956
J Nucl Med. 2002 Jan;43(1):117-24
pubmed: 11801714
J Biol Chem. 2002 Aug 2;277(31):27613-21
pubmed: 12000750
Molecules. 2015 Sep 03;20(9):16186-220
pubmed: 26404227
Bioorg Med Chem Lett. 2006 Jan 15;16(2):437-42
pubmed: 16290146
Antioxidants (Basel). 2016 Apr 19;5(2):
pubmed: 27104573
J Labelled Comp Radiopharm. 2019 May 15;62(5):202-208
pubmed: 30828860
Bioorg Med Chem Lett. 2018 Sep 15;28(17):2925-2929
pubmed: 30122224
ChemMedChem. 2006 Jun;1(6):603-10
pubmed: 16892400
Eur J Med Chem. 2011 Sep;46(9):4760-7
pubmed: 21640445
J Med Chem. 2019 Jan 24;62(2):688-698
pubmed: 30516998
Nucl Med Biol. 2018 Sep - Oct;64-65:47-56
pubmed: 30056279
Pharmacol Rep. 2010 Mar-Apr;62(2):233-44
pubmed: 20508278
J Labelled Comp Radiopharm. 2014 Apr;57(4):317-22
pubmed: 24470172
Front Oncol. 2013 Jul 11;3:181
pubmed: 23875171
Bioorg Med Chem. 2005 Mar 1;13(5):1811-8
pubmed: 15698799
Molecules. 2018 Aug 02;23(8):
pubmed: 30072617
Annu Rev Pharmacol Toxicol. 2009;49:265-90
pubmed: 18851701
Molecules. 2013 May 29;18(6):6311-55
pubmed: 23760031
Cardiovasc Res. 2007 Jul 15;75(2):390-7
pubmed: 17383621
Drug Metab Dispos. 2000 Mar;28(3):308-14
pubmed: 10681375
FASEB J. 1998 Sep;12(12):1063-73
pubmed: 9737710
ChemMedChem. 2015 Oct;10(10):1635-40
pubmed: 26287271
Appl Radiat Isot. 2017 Sep;127:260-268
pubmed: 28688368
Annu Rev Pharmacol Toxicol. 2001;41:443-70
pubmed: 11264465
Bioorg Med Chem. 2012 Jun 1;20(11):3410-21
pubmed: 22560838
Bioorg Med Chem. 2007 Feb 15;15(4):1802-7
pubmed: 17166726
Molecules. 2019 Oct 22;24(20):
pubmed: 31652609
Cancer Prev Res (Phila). 2011 Oct;4(10):1536-45
pubmed: 21900596
Biochem J. 2002 Sep 15;366(Pt 3):831-7
pubmed: 12076251
J Med Chem. 2019 Jun 13;62(11):5276-5297
pubmed: 30640460
J Nucl Med. 2016 Feb;57(2):315-20
pubmed: 26585057
Nucl Med Biol. 2009 Jan;36(1):29-38
pubmed: 19181266
Bioorg Chem. 2019 Aug;89:103007
pubmed: 31132600
J Chromatogr A. 2002 Apr 5;952(1-2):47-61
pubmed: 12064545
Nat Rev Cancer. 2010 Mar;10(3):181-93
pubmed: 20168319
Drug Des Devel Ther. 2018 May 24;12:1467-1478
pubmed: 29872269
Appl Biochem Biotechnol. 2010 Mar;160(6):1699-722
pubmed: 19582595
Bioorg Med Chem. 2013 Feb 1;21(3):643-52
pubmed: 23290251
Bioorg Med Chem Lett. 2005 Nov 1;15(21):4699-702
pubmed: 16153836
Bioorg Med Chem. 2013 Mar 15;21(6):1451-64
pubmed: 23168081
Medchemcomm. 2016 Dec 12;8(3):492-500
pubmed: 30108767
Bioorg Med Chem. 2011 May 1;19(9):2997-3004
pubmed: 21482120
J Med Chem. 2004 Jan 29;47(3):550-7
pubmed: 14736236
J Natl Cancer Inst. 2006 Jun 7;98(11):736-47
pubmed: 16757698
Nucl Med Biol. 2006 Jan;33(1):21-7
pubmed: 16459255